scholarly journals SAT-271 DETERMINING THE OPTIMAL DOSE OF CHOLECALCIFEROL SUPPLEMENTATION IN CHILDREN WITH CHRONIC KIDNEY DISEASE (C3 TRIAL) - AN OPEN LABEL MULTICENTRE RANDOMIZED CONTROLLED TRIAL

2019 ◽  
Vol 4 (7) ◽  
pp. S120-S121
Author(s):  
N. Kamath ◽  
A. Iyengar ◽  
H. V Reddy ◽  
S. Uthup ◽  
J. Sharma ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Randomized Controlled Trial ◽  
Kidney Disease ◽  
Controlled Trial ◽  
Optimal Dose ◽  
Open Label ◽  
Randomized Controlled ◽  
Cholecalciferol Supplementation

scholarly journals Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease

2018 ◽  
Vol 12 (1) ◽  
pp. 129-138 ◽  
Author(s):  
Louis Holdstock ◽  
Borut Cizman ◽  
Amy M Meadowcroft ◽  
Nandita Biswas ◽  
Brendan M Johnson ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Randomized Controlled Trial ◽  
Kidney Disease ◽  
Controlled Trial ◽  
Open Label ◽  
Randomized Controlled

Dyslipidemia in chronic kidney disease: randomized controlled trial of colestilan versus simvastatin in dialysis patients

2014 ◽  
Vol 82 (09) ◽  
pp. 163-172 ◽  
Author(s):  
Chistoph Wanner ◽  
Winfried März ◽  
Andrei Varushchanka ◽  
Natallia Apanasovich ◽  
Nickolay Dosta ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Randomized Controlled Trial ◽  
Kidney Disease ◽  
Controlled Trial ◽  
Dialysis Patients ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document